Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Refractory or Recurrent Solid Tumors, Excluding CNS Tumors”

3 trials

Showing 3 of 3 results

Early research (Phase 1)WithdrawnNCT02800889
What this trial is testing

Dose-Escalation Study of Pixantrone Monotherapy in Pediatric Patients With Relapsed or Refractory Cancer

Who this might be right for
LymphomaSolid Tumor (Excluding CNS)
CTI BioPharma
Early research (Phase 1)Study completedNCT02164838
What this trial is testing

VEGF Receptor Tyrosine Kinase Inhibitor Axitinib in Children With Recurrent or Refractory Solid Tumors

Who this might be right for
Refractory or Recurrent Solid Tumors, Excluding CNS Tumors
Children's Oncology Group 51
Early research (Phase 1)Study completedNCT02171260
What this trial is testing

This is a Phase 1 Study of Eribulin Mesylate in Pediatric Participants With Recurrent or Refractory Solid Tumors (Excluding [Central Nervous System] CNS), Including Lymphomas

Who this might be right for
PediatricsSolid Tumors
Eisai Inc. 23

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation